Brian DelGhiaccio
Analyst · Goldman Sachs. Please go ahead.
Sure. Just to give you an idea, if we've talked about, right, several investments, you've got the RNG portfolio, you've got polymer center and you have Blue Polymers, some of which is going to come through capital, some of which is going to be the investment in the JVs just to kind of think it from a cumulative perspective here, maybe I'll walk through each from polymer centers, we see a total investment of around $300 million, okay, for the four centers. right? And that's going to happen, right? It's happened, and we think that's over a four-year time frame of about $70 million a year. Blue Polymers, you can think of that being about $160 million investment. And again, those are going to be JVs. So that will come through as an investment in those joint ventures. And then the investment in the RNG portfolio is all around $375 million, okay? So those are the cumulative investments, but we've been making those investments. So those are somewhat in our run rate. Now -- and we talked about that after the US Ecology acquisition, where leverage elevates to 3.4 times, we were going to focus on deleveraging, getting back to that three times before we resume the share repurchase, got back to 2.9 times. We have since resumed, right, that share repurchase program. And as you just saw in the announcement, right, the Board just authorized another $3 billion program that extends over the next three years beginning in 2024 through the end of 2026.